Search research articles
Contact Us
Filters
Showing results (261-270 of 330) with videos related to
Page
of 33
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 18, 2015
TBCRC 019: A Phase II Trial of Nanoparticle Albumin-Bound Paclitaxel with or without the Anti-Death Receptor 5 Monoclonal Antibody Tigatuzumab in Patients with Triple-Negative Breast Cancer
Andres Forero-Torres, Katherine E Varley, Vandana G Abramson, et al.
NPJ Breast Cancer
|
January 3, 2024
Qualification of a multiplexed tissue imaging assay and detection of novel patterns of HER2 heterogeneity in breast cancer
Jennifer L Guerriero, Jia-Ren Lin, Ricardo G Pastorello, et al.
JAMA Oncology
|
December 11, 2025
Cognitive Impairment and Chemoendocrine vs Endocrine Therapy in Pre- and Postmenopausal Women: A Secondary Analysis of the RxPONDER Randomized Clinical Trial
Irene M Kang, Jamie K Forschmiedt, Michelle M Loch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 6, 2020
Tumor Mutational Burden and <i>PTEN</i> Alterations as Molecular Correlates of Response to PD-1/L1 Blockade in Metastatic Triple-Negative Breast Cancer
Romualdo Barroso-Sousa, Tanya E Keenan, Sonia Pernas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 4, 2018
Association of Cell-Free DNA Tumor Fraction and Somatic Copy Number Alterations With Survival in Metastatic Triple-Negative Breast Cancer
Daniel G Stover, Heather A Parsons, Gavin Ha, et al.
Neuro-Oncology
|
June 28, 2022
Brain metastases: A Society for Neuro-Oncology (SNO) consensus review on current management and future directions
Ayal A Aizer, Nayan Lamba, Manmeet S Ahluwalia, et al.
Journal of the National Cancer Institute
|
December 10, 2024
Race and clinical outcomes in hormone receptor-positive, HER2-negative, node-positive breast cancer in the randomized RxPONDER trial
Yara Abdou, William E Barlow, Julie R Gralow, et al.
Nature Biomedical Engineering
|
April 6, 2019
Solid stress in brain tumours causes neuronal loss and neurological dysfunction and can be reversed by lithium
Giorgio Seano, Hadi T Nia, Kyrre E Emblem, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 1, 2022
Identification and Management of Pathogenic Variants in BRCA1, BRCA2, and PALB2 in a Tumor-Only Genomic Testing Program
Brittany L Bychkovsky, Tianyu Li, Jilliane Sotelo, et al.
Breast Cancer Research and Treatment
|
July 5, 2024
A randomized phase III double-blind placebo-controlled trial of first-line chemotherapy and trastuzumab with or without bevacizumab for patients with HER2/neu-positive metastatic breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1105)
Jessica Mezzanotte-Sharpe, Anne ONeill, Ingrid A Mayer, et al.
Page
of 33
Search research articles
Search
Showing results (261-270 of 330) with videos related to
Sort By:
Page
of 33
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 18, 2015
TBCRC 019: A Phase II Trial of Nanoparticle Albumin-Bound Paclitaxel with or without the Anti-Death Receptor 5 Monoclonal Antibody Tigatuzumab in Patients with Triple-Negative Breast Cancer
Andres Forero-Torres, Katherine E Varley, Vandana G Abramson, et al.
NPJ Breast Cancer
|
January 3, 2024
Qualification of a multiplexed tissue imaging assay and detection of novel patterns of HER2 heterogeneity in breast cancer
Jennifer L Guerriero, Jia-Ren Lin, Ricardo G Pastorello, et al.
JAMA Oncology
|
December 11, 2025
Cognitive Impairment and Chemoendocrine vs Endocrine Therapy in Pre- and Postmenopausal Women: A Secondary Analysis of the RxPONDER Randomized Clinical Trial
Irene M Kang, Jamie K Forschmiedt, Michelle M Loch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 6, 2020
Tumor Mutational Burden and <i>PTEN</i> Alterations as Molecular Correlates of Response to PD-1/L1 Blockade in Metastatic Triple-Negative Breast Cancer
Romualdo Barroso-Sousa, Tanya E Keenan, Sonia Pernas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 4, 2018
Association of Cell-Free DNA Tumor Fraction and Somatic Copy Number Alterations With Survival in Metastatic Triple-Negative Breast Cancer
Daniel G Stover, Heather A Parsons, Gavin Ha, et al.
Neuro-Oncology
|
June 28, 2022
Brain metastases: A Society for Neuro-Oncology (SNO) consensus review on current management and future directions
Ayal A Aizer, Nayan Lamba, Manmeet S Ahluwalia, et al.
Journal of the National Cancer Institute
|
December 10, 2024
Race and clinical outcomes in hormone receptor-positive, HER2-negative, node-positive breast cancer in the randomized RxPONDER trial
Yara Abdou, William E Barlow, Julie R Gralow, et al.
Nature Biomedical Engineering
|
April 6, 2019
Solid stress in brain tumours causes neuronal loss and neurological dysfunction and can be reversed by lithium
Giorgio Seano, Hadi T Nia, Kyrre E Emblem, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 1, 2022
Identification and Management of Pathogenic Variants in BRCA1, BRCA2, and PALB2 in a Tumor-Only Genomic Testing Program
Brittany L Bychkovsky, Tianyu Li, Jilliane Sotelo, et al.
Breast Cancer Research and Treatment
|
July 5, 2024
A randomized phase III double-blind placebo-controlled trial of first-line chemotherapy and trastuzumab with or without bevacizumab for patients with HER2/neu-positive metastatic breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1105)
Jessica Mezzanotte-Sharpe, Anne ONeill, Ingrid A Mayer, et al.
Page
of 33